NCT07718334

Brief Summary

This study aims to evaluate the impact of using a mobile application-based medication reminder on medication adherence among patients diagnosed with chronic diseases and memory impairment. Adherence to prescribed therapy is a significant challenge for this patient population, often leading to poor health outcomes and increased healthcare costs. From a nursing leadership perspective, innovative digital solutions can play a crucial role in supporting patient self-management. Using a quasi-experimental design, the study will investigate whether a customized mobile reminder system can effectively improve adherence rates and support patients in managing their therapeutic regimens.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P75+ for not_applicable

Timeline
1mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
May 2026Sep 2026

Study Start

First participant enrolled

May 10, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 21, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

July 21, 2026

Status Verified

July 1, 2026

Enrollment Period

4 months

First QC Date

July 14, 2026

Last Update Submit

July 18, 2026

Conditions

Keywords

medication adherencemobile applicationmedication remindernursing leadershipquasi-experimental study

Outcome Measures

Primary Outcomes (1)

  • Medication Adherence (MMAS-8)

    Medication adherence will be assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). This self-reported tool evaluates patients' behaviors regarding taking their prescribed chronic medications. Total scores range from 0 to 8, where a score of 8 indicates high adherence, 6 to \<8 indicates medium adherence, and \<6 indicates low adherence.

    Baseline (pre-intervention) and 3 months post-intervention

Secondary Outcomes (4)

  • Objective Medication Adherence: Medication Possession Ratio (MPR)

    3 months post-intervention

  • Objective Medication Adherence: Proportion of Days Covered (PDC)

    3 months post-intervention

  • Cognitive Function Status (MMSE)

    Baseline

  • Perceived Nursing Care and Leadership Support

    3 months post-intervention.

Study Arms (1)

Mobile Application Group

EXPERIMENTAL

Participants in this single-group study will receive training on and utilize a customized mobile application-based medication reminder designed to support adherence to their therapeutic regimens.

Device: Mobile Application-Based Medication Reminder

Interventions

The intervention consists of a mobile application specifically designed to support medication adherence. It features automated push notifications, customized reminder alerts matching prescribed medication schedules, and tracking logs. Participants will be instructed on how to install, configure, and use the application on their personal smartphones. The system is designed to provide immediate prompts to overcome memory-related adherence barriers.

Mobile Application Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with one or more chronic diseases requiring regular long-term medication.
  • Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE).
  • Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application.
  • Patients aged 18 years and older.
  • Patients who provide voluntary informed consent to participate in the study.

You may not qualify if:

  • Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance.
  • Patients with severe acute clinical complications or unstable psychiatric conditions.
  • Patients participating in another concurrent clinical trial or study targeting medication adherence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Outpatient Clinics, Delta University for Science and Technology

Gamasa, Dakahlia Governorate, Egypt

RECRUITING

Outpatient Clinics, Kafr El-Sheikh Hospital

Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt

RECRUITING

MeSH Terms

Conditions

Chronic DiseaseMemory DisordersMedication Adherence

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

Asmaa Elwan Hassan, PhD

CONTACT

Mona Ahmed Gabr, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Nursing Administration, Faculty of Nursing, Mansoura University, Egypt

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 21, 2026

Study Start

May 10, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

July 21, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to ensure the confidentiality and privacy of the patients' medical records and personal information.

Locations